Aldwych Partners assesses and advises on the risk of CMA intervention for both individual transactions and longer-term buy-and-build strategies.
For individual transactions, we carry out early stage risk assessments to advise on the likelihood of CMA intervention and the best strategy for engaging with the CMA. We help identify measures, such as asset sales or carve outs, that will reduce the risk of CMA intervention or an adverse decision by the CMA. We provide rapid assessments for transactions working to accelerated timetables.
For buy-and-builds, we advise on longer-term measures to manage the risk of CMA intervention. Our white paper discusses the unique CMA intervention risk profile for buy-and-builds and actions that can be taken to mitigate these risks.